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A G protein-coupled receptor (GPCR) functions not only as a monomer or homodimer
but also as a heterodimer with another GPCR. GPCR heterodimerization results in the
modulation of the molecular functions of the GPCR protomer, including ligand binding
affinity, signal transduction, and internalization. There has been a growing body of reports
on heterodimerization of multiple GPCRs expressed in the reproductive system and the
resultant functional modulation, suggesting that GPCR heterodimerization is closely asso-
ciated with reproduction including the secretion of hormones and the growth and matura-
tion of follicles and oocytes. Moreover, studies on heterodimerization among paralogs of
gonadotropin-releasing hormone (GnRH) receptors of a protochordate, Ciona intestinalis,
verified the species-specific regulation of the functions of GPCRs via multiple GnRH recep-
tor pairs. These findings indicate that GPCR heterodimerization is also involved in creating
biodiversity. In this review, we provide basic and current knowledge regarding GPCR het-
erodimers and their functional modulation, and explore the biological significance of GPCR
heterodimerization.
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INTRODUCTION
The development of “omics” technologies and ensuring construc-
tion of a variety of databases provide vast information regarding
primary sequences and functional domains of genes and proteins
in diverse organisms, leading to annotation or prediction of bio-
chemical and pharmacological propensities of novel genes and
proteins. Even in this post-genomic era, several functions of pro-
teins have yet to be fully elucidated or predicted. One of the most
unpredictable and confounding post-translational protein func-
tions is the heterodimerization of G protein-coupled receptors
(GPCRs).
Currently, a wide range of GPCRs have been proved to func-
tion not only as monomers or homodimers but also as het-
erodimers formed after translation. It has been shown that GPCR
heterodimerization alters or fine-tunes ligand binding, signal-
ing, and internalization of GPCR protomers (1–9). The greatest
difficulty in studies on GPCR heterodimers lies in the lack of pro-
cedures for the prediction of either GPCR protomer pairs for het-
erodimerization or the resultant functional alteration of GPCRs.
Consequently, high-throughput analysis of GPCR heterodimers
(e.g., “GPCR heterodimerome”) has not yet been accomplished.
Despite this shortcoming, there have been increasing findings
regarding the biological and pathological significance of GPCR
heterodimerization.
Reproduction is regulated by diverse neuropeptides and hor-
mones, with the receptors belonging to the GPCR family,
e.g., melatonin, kisspeptin, neurokinin B (NKB), gonadotropin-
inhibitory hormone (GnIH), gonadotropin-releasing hormone
(GnRH), luteinizing hormone (LH), follicle-stimulating hormone
(FSH), and prostanoids (10–13). In vertebrates, these hormones
and neuropeptides play crucial roles in the hypothalamus-
pituitary-gonad (HPG) axis (Figure 1). Furthermore, various
species-specific GPCRs for highly conserved cognate hormones
or neuropeptides have been identified (14–18, Kawada et al.,
forthcoming). Collectively, these findings suggest that GPCR het-
erodimerization participates in the fine-tuning and diversification
of reproductive functions. In this article, we provide an overview
of GPCR heterodimerization and discuss the implication of GPCR
heterodimers in reproductive functions and their diversification.
GPCR PROTOMERS AS ALLOSTERIC MODULATORS
It is widely accepted that GPCRs can assume various active
conformations which enable coupling with distinct G pro-
teins and other associated proteins followed by particular sig-
nal transduction cascades (3, 8, 19, 20). Moreover, allosteric
effectors interact with GPCRs at binding sites different from
those for agonists or antagonists and modulate the confor-
mations of GPCRs, leading to alterations in agonist/antagonist
binding affinity or signal transduction (3, 8, 19, 20). Also of
significance is that each of the active conformations responsi-
ble for individual signaling pathways is not interconvertible (3,
8, 19–21). Combined with experimental evidence that ligand
binding and signaling of GPCR protomers are altered via het-
erodimerization, GPCR heterodimerization is believed to induce
protomer-specific modulation (i.e., stabilization or instabiliza-
tion) of active conformations as an endogenous allosteric mod-
ulator. This view is compatible with the fact that a single
GPCR protomer acquires diverse biochemical and/or pharma-
cological properties via heterodimerization with different GPCR
partners.
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FIGURE 1 | Major GPCRs for neuropeptides or hormones in the
hypothalamus-pituitary-gonad (HPG) axis.
TYPICAL FUNCTIONAL CONSEQUENCES OF GPCR
HETERODIMERIZATION
Obviously, colocalization of GPCR protomers in a cell is a prereq-
uisite for the formation of the corresponding GPCR heterodimer
in native tissues. However, many early studies demonstrated func-
tional alteration of GPCRs only after co-transfection of cultured
cells with two GPCRs but not at the level of endogenous co-
expression in the same cells in a particular native tissue. Con-
sequently, the biological and physiological significance of such
“in vitro-only” GPCR heterodimers is highly questionable. Con-
sistent with this, the International Union of Basic and Clinical
Pharmacology (IUPHAR) release the paradigm for GPCR het-
erodimer studies in 2007 (2). First, interaction between GPCR
protomers in native tissues should be proved by at least two differ-
ent experimental procedures including co-immunoprecipitation,
fluorescence resonance energy transfer (FRET), or biolumines-
cence resonance energy transfer (BRET). Second, alteration of
biochemical or pharmacological functions of GPCRs should be
observed in native tissues or co-transfected cells. Third, biolog-
ical roles of GPCR heterodimers should be verified using gene-
knockout or gene-silenced procedures. At present, meeting all
of these criteria is too difficult. Thus, IUPHAR proposed that
researchers fulfill at least two of the three criteria. In the following,
we focus on GPCR heterodimers which were detected in native
tissues (Table 1).
G protein-coupled receptor heterodimers are classified into
two groups in light of their functions: obligatory and non-
obligatory GPCR heterodimers. Obligatory GPCR heterodimers
require heterodimerization of GPCR protomers to serve as func-
tional receptors, such as gamma amino butyric acid (GABA) type
B receptor and taste receptors. GABARB1 alone is sequestered
in the endoplasmic reticulum (ER) due to the presence of an
ER retention signal, which is masked by heterodimerization with
Table 1 |Typical functional alteration of GPCRs via heterodimerization.
Heterodimer Effect
GABARB1–GABARB2 Transition from ER to plasma membrane and
function
T1R1–T1R3 Recognition of umami substances
T1R2–T1R3 Recognition of sweet substances
AT1–B2 Increase of IP3 accumulation induced by
angiotensin II or bradykinin
MOR–DOR Reduction in binding affinity of Met-enkephalin
Increase in binding affinity of endomorphin-1 and
Leu-enkephalin
Shift of coupling of Gz to Gi
KOR–DOR Enhancement of signaling induced by synthetic
KOR agonists
OR1–CB1 Suppression of OR-triggered ERK phosphorylation
by a CB1 antagonist
Suppression of CB-triggered ERK phosphorylation
by a OR1 antagonist
MC3R–GHSR Increase in cAMP production induced by
melanocortin
Decrease in ghrelin-induced signaling
D1–D2 Shift of coupling of Gs to Gq/11
MT1–GPR50 Decrease of melatonin-binding,
Gi-coupling/signaling, and internalization
NK1–MOR Alternation of internalization and resensitization
profile
R1–R4 Upregulation of ERK phosphorylation via
Ca2+-dependent PKCα activation and
Ca2+-independent PKCζ activation
R2–R4 Reduction in cAMP production via shift of coupling
of Gs to Gi
EP1–β2AR Dissociation of Gs from bA2R induced by EP1
agonists
GABAR, GABA receptor; T1R, taste receptor; AT1, angiotensin receptor 1; B2
bradykinin receptor 2; MOR, µ-opioid receptor; DOR, δ-opioid receptor; KOR,
κ-opioid receptor; OR1, orexin receptor 1; CB1, cannabinoid receptor 1; MC3R,
melanocortin receptor 3; GHSR, ghrelin receptor; D1, dopamine receptor 1; MT1,
melatonin receptor 1, NK1, tachykinin receptor 1; Ci-GnRHR, Ciona intestinalis
GnRH receptor; EP1, prostaglandin E2 receptor 1.
GABARB2 (22–24). Moreover, the GABARB1 protomer harbors a
ligand-binding site, whereas the GABARB2 protomer merely cou-
ples to G proteins (22–24). Therefore, the GABARB1 -GABARB2
heterodimer serves as an authentic GABA receptor. Taste recep-
tors also exhibit heterodimerization-dependent pharmacological
profiles. The heterodimer between T1R1 and T1R3 is exclusively
responsive to umami taste, while the T1R2–T1R3 heterodimer is
a specific receptor for sweet taste-inducing molecules (25–27).
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In contrast, non-obligatory GPCR heterodimers are com-
posed of the functional GPCR protomers and modulate the
biochemical or pharmacological activities of the protomers
(Table 1). Non-obligatory GPCR heterodimers account for the
major population and exhibit diverse modulatory functions.
In human embryonic kidney (HEK) 293 cells expressing the
angiotensin II receptor (AT1)-bradykinin receptor (B2) het-
erodimer, angiotensin II triggered inositol triphosphate (IP3)
accumulation much more potently and effectively than it did
in the cells expressing AT1 alone, whereas IP3 accumulation by
bradykinin was slightly weaker in cells expressing the AT1–B2 het-
erodimer than in the cells expressing only B2 (28). This enhance-
ment was also detected in vivo, where AT1 and B2 were shown
to form a heterodimer in smooth muscle, omental vessel, and
platelets (28, 29).
The opioid receptor family is composed of three subtypes,
namely, µ-, δ-, and κ-opioid receptors (MOR, DOR, and KOR),
all of which mediate inhibition of cAMP production with differ-
ent ligand-selectivity (30). Co-expression of MOR and DOR in
HEK293 cells resulted in a 10-fold reduction in binding affinity
of a synthetic MOR-selective agonist, DAMGO (31). Moreover,
the MOR-DOR heterodimer differs in rank order of affinities
for endogenous peptide ligands; Met-enkephalin, possessing the
highest affinity for MOR among endogenous opioid peptides,
exhibited twofold lower affinity to the MOR-DOR heterodimer,
while the affinity of endomorphin-1 and Leu-enkephalin to the
heterodimer was increased two to threefold, compared to MOR
(31). Moreover, heterodimerization of MOR and DOR predom-
inantly induced activation of a pertussis toxin-insensitive G pro-
tein, Gz in COS-7 cells, while monomeric or homodimeric MOR
and DOR were coupled to a pertussis toxin-sensitive G pro-
tein, Gi (32). This is consistent with findings that the binding
of ligands to the MOR–DOR heterodimer followed by signal
transduction is resistant to pertussis toxin (32). A KOR-selective
agonist, U69593, exhibited as potent and efficacious activities at
the heterodimer as at KOR, whereas 6′-GNTI was a sixfold more
potent agonist for the KOR–DOR heterodimer than for the KOR
homodimer (33). More recently, N -naphthoyl-β-naltrex-amine
(NNTA), a potent antagonist for MOR, was shown to mani-
fest a prominent agonistic activity at MOR–DOR (34). In the
mouse tail-flick assay, intrathecal NNTA elicited 100-fold greater
antinociception, compared to intracerebroventricular administra-
tion (34). These heterodimerization-based pharmacological alter-
ations are expected to provide crucial clues to understand why
various in vivo pharmacological profiles are inconsistent with
those from in vitro studies using cells expressing each opioid recep-
tor alone and to develop more specific clinical agents for opioid
receptors.
When an orexin receptor OR1 was co-expressed with a cannabi-
noid receptor CB1 in HEK293 cells, addition of a CB1-specific
antagonist, SR-141716A, resulted in the suppression of orexin-
triggered phosphorylation of ERK1/2 (35). Likewise, an OR1-
specific antagonist, SB-674042, attenuated the ERK phosphory-
lation activated by a CB1 agonist, WIN55212-2 (35). These data
verify the regulatory mechanism by which one GPCR protomer
bound to an antagonist modulates the pharmacological profile of
another GPCR protomer through heterodimerization.
Melanocortin receptor 3 (MC3R) and ghrelin receptor (GHSR)
were found to be co-expressed in a number of neurons in the
arcuate nucleus (36, 37). Co-transfection of MC3R and GHSR
into COS-7 cells enhanced melanocortin-induced intracellular
cAMP accumulation, compared with activation of MC3R in the
absence of GHSR, whereas both agonist-independent basal and
ghrelin-induced signaling of GHSR were diminished (36). These
findings reveal mutual opposite signal modulation by each pro-
tomer and suggest that the molecular mechanism underlying a
certain agonist-independent active conformation of a protomer is
also involved in the regulation of the signaling functionalities of its
partner GPCR in a heterodimer. Since MC3R and GHSR play piv-
otal roles in the orexigenic system, the MC3R–GHSR heterodimer
is involved in hypothalamic body weight regulation.
There is increasing evidence for a pathological relevance
of GPCR heterodimer. AT1–B2 heterodimer is highly likely to
be functionally correlated with preeclampsia. The AT1–B2 het-
erodimer was more abundant on platelets of preeclamptic women
than on platelets of normotensive pregnant women (29). Such
increase in the number of heterodimers is due to enhanced expres-
sion of B2, as the expression level of B2 was elevated four to
fivefold on platelets of preeclamptic women compared to platelets
of normotensive pregnant women, whereas expression of AT1 was
unchanged (29). Moreover, mobilization of intracellular calcium
ions induced by angiotensin II was up-regulated 1.7- to 1.9-fold
in platelets of preeclamptic women, compared to normotensive
pregnant women (28, 29).
Heterodimerization between dopamine receptor subtypes, D1
and D2, has shown to be implicated in depression. The D1–D2
heterodimer was detected at higher levels in the post-mortem
striatum of the patients compared to in normal subjects using
co-immunoprecipitation and D1–D2 heteromer-selective anti-
bodies (38). Moreover, dissociation of the D1–D2 heterodimer
by an interfering peptide that disrupts the heteromer resulted in
substantially reduced immobility in the forced swim test with-
out affecting locomotor activity, and decreased escape failures in
learned helplessness tests in rats (38). It should be noted that the
heterodimerization between D1 and D2 leads to a drastic shift of G
protein coupling; D1 and D2 monomer/homomer are coupled to
Gs and Gi, respectively, while Gq/11 is a major G protein-coupled
to the D1–D2 heterodimer (39).
More recently, MOR–DOR heterodimer was found to play piv-
otal roles in the opioid system. An interaction-disrupting peptide
fragment for the MOR–DOR heterodimer enhanced morphine
analgesia and reduced anti-nociceptive tolerance to morphine in
mice (40).
HETERODIMERS AMONG REPRODUCTION – ASSOCIATED
GPCRs
MELATONIN RECEPTOR
Melatonin participates in reproductive functions via upregulation
of the synthesis and secretion of GnIH in the hypothalamus of
mammals and birds (10, 11). Moreover, melatonin receptors were
also shown to be expressed in gonads (41), and melatonin signif-
icantly decreases testosterone secretion from LH/FSH-stimulated
testes of European starlings before breeding (42). Two class A
(rhodopsin-like) GPCRs for melatonin, MT1 and MT2, have been
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identified in mammals (1, 43). A human orphan GPCR, GPR50,
sharing the highest sequence homology with MT1 and MT2, was
shown to form a heterodimer with both receptors in HEK293
cells (1, 43). Moreover, heterodimerization of GPR50 with MT1
resulted in a marked reduction of the ability of MT1 to bind to
ligands and to couple to G proteins, resulting in decreased in Gi
protein-coupled intracellular signaling and β-arrestin – assisted
internalization in HEK293 cells, whereas functions of MT2 were
not affected (1, 43). These data indicate that GPR50 antagonizes
MT1 but not MT2 via heterodimerization. In addition, this is
the first report on the functional role of an orphan receptor as a
protomer of a GPCR heterodimer.
TACHYKININ RECEPTOR
Tachykinins (TKs) are vertebrate and ascidian multifunctional
brain/gut peptides involved in smooth muscle contraction, vasodi-
lation, nociception, inflammation, neurodegeneration, and neu-
roprotection in a neuropeptidergic endocrine, paracrine fash-
ion (44–48). The mammalian TK family consists of four major
peptides: Substance P (SP), Neurokinin A (NKA), NKB, and
Hemokinin-1/Endokinins (HK-1/EKs) (EK is a human homolog
of mouse and rat HK-1). TK receptors belong to the class A
GPCR family. Three subtypes of TK receptors, namely NK1,
NK2, and NK3, have been identified in mammals, and sev-
eral submammalian orthologs have been cloned or suggested
by genomic database search. In the ascidian, Ciona intestinalis,
authentic TK, and its cognate receptor, Ci-TK-I and Ci-TK-R
were identified (49, 50). Recently, there are accumulating reports
on reproductive roles of TKs as well as the expression of TKs
and TK receptors in genital organs of mammals (46, 48, 49,
51–54). In C. intestinalis, Ci-TK-I enhances oocyte growth from
the vitellogenic stage to the post-vitellogenic stage via upreg-
ulation of gene expression and enzymatic activity of several
proteases such as cathepsin D, carboxypeptidase B1, and chy-
motrypsin (55–57). Over the past few years, there has been
increasing evidence that NKB plays a central role in the direct
enhancement of GnRH synthesis and release in the hypothal-
amus of mammals, eventually leading to the recognition of
novel regulatory function in sexual maturation and reproduction
[(58–65)].
Only one tachykinin receptor-relevant heterodimer has thus
far been identified. NK1 and an opioid receptor subtype, MOR,
were shown to co-exist in pain-processing brain regions, includ-
ing trigeminal dorsal horn neurons, and to heterodimerize in
co-transfected HEK293 cells (66). NK1–MOR heterodimeriza-
tion altered their internalization and resensitization profile, while
ligand binding and signaling intensities of the protomers were
not affected. In cells expressing NK1–MOR heterodimer, both
DAMGO and SP induced the recruitment of β-arrestin to
the plasma membrane and internalization of NK1–MOR het-
erodimers with β-arrestin into the same endosomal compartment
(66). Recent studies also verified that other tachykinin recep-
tors, such as NK3, are co-localized with various GPCRs includ-
ing kisspeptin receptors and opioid receptors (59). Consequently,
tachykinin receptors are expected to form heterodimers with a
wide variety of GPCRs, which, in turn, are potentially involved
in the molecular mechanisms underlying novel reproductive
functions.
GnRH RECEPTOR
Gonadotropin-releasing hormones are hypothalamic decapep-
tides that regulate the HPG axis to control reproduction by
releasing gonadotropins, FSH, and LH from the pituitary in ver-
tebrates (Figure 1). The endogenous receptors, GnRHRs, which
belong to the Class A GPCR family, have also been shown to pos-
sess species-specific paralogs forms in vertebrates. Type I GnRHRs,
which completely lack a C-terminal tail region, are restricted to
humans, rodents, and cows (14–16, 67, 68). Type II GnRHRs,
which bear a C-terminal tail, are widely distributed throughout
almost all vertebrates, whereas the type II gnrhr gene is silenced
due to a deletion of functional domains or interruption of full-
length translation by the presence of a stop codon in humans,
chimpanzees, cows, and sheep (14–16, 67, 68). To date, no convinc-
ing evidence for heterodimerization of GnRHRs in native tissues
has been provided.
Gonadotropin-releasing hormones have also been identified in
a wide range of invertebrates that lack a pituitary (Kawada et al.,
forthcoming). To date, seven GnRH peptides (tGnRH-3 to -8 and
Ci-GnRH-X) and four GnRH receptor subtypes (Ci-GnRHR-1 to
-4) have been identified in C. intestinalis (69–71). Molecular phy-
logenetic analysis indicates that Ci-GnRHR2 (R2), R3, and R4 are
Ciona-specific paralogs of R1 generated via gene duplication (70,
72). Only R1 activated IP3 generation followed by intracellular
Ca2+ mobilization in response to tGnRH-6, whereas R2 and R3
exclusively stimulate cAMP production in response to multiple
tGnRHs; tGnRH-6, -7, and -8 exhibited near-equipotent cAMP
production via R2, which was 100-fold more potent than tGnRH-
3, -4, and -5. tGnRH-3 and -5 specifically triggered R3-mediated
cAMP production (70, 73–75). R4 is devoid of binding to any
tGnRHs or of activating any signaling pathways (70). Recently, we
have shown that the orphan paralog, R4, is responsible for the fine-
tuning of the GnRHergic signaling via heterodimerization with R1.
The R1–R4 heterodimer elicited a 10-fold more potent Ca2+ mobi-
lization than R1 monomer/homodimer in a tGnRH-6-selective
manner, while cAMP production by R1 was not modulated via
heterodimerization with R4 (73). The R1–R4 heterodimer poten-
tiated translocation of both Ca2+-dependent PKCα by tGnRH-6
and Ca2+-independent PKCζ by tGnRH-5 and -6, eventually lead-
ing to upregulation of ERK phosphorylation, compared with R1
alone (73). These results provide evidence that the species-specific
GnRHR orphan paralog, R4, serves as an endogenous modula-
tor for the fine-tuning of the activation of PKC subtype-selective
signal transduction via heterodimerization with R1. R4 was also
shown to heterodimerize with R2 specifically in test cells of vitel-
logenic oocytes (74). Of particular interest is that the R2–R4
heterodimer in HEK293 cells decreased cAMP production in a
non-ligand selective manner via a shift from activation of Gs pro-
tein to Gi protein by R2, compared with R2 monomer/homodimer
(74). Considering that R1–R4 elicited a 10-fold more potent Ca2+
mobilization than R1 monomer/homodimer in a ligand selective
manner but did not affect cAMP production, these results indi-
cate that R4 regulates differential GnRH signaling cascades via
heterodimerization with R1 and R2 as an endogenous allosteric
modulator. Collectively, these studies suggest that heterodimer-
ization among GnRHR paralogs, including the species-specific
orphan receptor subtype, is involved in rigorous and diversified
GnRHergic signaling in a protochordate lacking an HPG axis.
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LH RECEPTOR
Luteinizing hormone is a central pituitary peptide hormone
responsible for gonadal maturation (Figure 1). A single GPCR for
LH has been identified in mammals. Although no LH receptor-
containing GPCR heterodimer has been detected, studies on LH
homodimers suggests that LH can also serve as a multifunc-
tional protomer in various GPCR heterodimers. Co-expression
of a ligand-binding-deficient LH receptor mutant and a signaling-
deficient LH receptor mutant resulted in the restoration of normal
gonadal and genital function in transgenic mice, indicating that
LH receptor functions as a dimer in vivo (76).
PROSTAGLANDIN RECEPTOR
Prostanoids consist of prostaglandin (PG) D, PGE2, PGF2α, PGI2,
and thromboxane A2 and are responsible for a variety of actions in
various tissues including the relaxation and contraction of various
types of smooth muscles, pain transmission, fever generation, and
sleep induction (77). Numerous studies have also proved that ovu-
lation, corpus luteum development and regression are mediated
by PGs (78–80). To date, eight GPCRs for PGs have been identified
in mammals. Heterodimerization of a PGE2 receptor, EP1, with
β2 adrenergic receptor (β2AR) caused considerable reduction in
cAMP production by β2AR via enhancement of the dissociation
of Gs protein from β2AR in the presence of endogenous or syn-
thetic EP1 agonists in primary cultures of airway smooth muscle
or COS-7 cells (81). Of importance in the functional regulation by
the GPCR heterodimer is that EP1 have a direct inhibitory effects
on bronchodilatory signaling but rather modulates the function
of the β2AR. These findings strongly suggest that the heterodimer-
ization of β2AR with EP1 causes the β2-agonist resistance found
in asthma (81).
EFFECTS OF GPCR HETERODIMERIZATION ON
DIVERSIFICATION OF ANIMAL SPECIES AND BIOLOGICAL
FUNCTION
G protein-coupled receptors are largely categorized into two
groups. The first group consists of GPCRs conserved as authen-
tic “homologs” in various species, and the second one includes
species-specific GPCRs. The latter is further classified into GPCRs
for species-specific ligands and subtypes of GPCRs for highly
conserved ligands in various species. For instance, C. intestinalis
GnRH receptors consists of four GPCRs as stated above: R1, R2,
R3, and R4. Phylogenetic tree and biochemical analyses proved
that R1 is structurally and functionally homologous to vertebrate
GnRH receptors, whereas R2, R3, and R4 areC. intestinalis-specific
paralogs that occurred via gene duplication in the Ciona evolu-
tionary lineage (70, Kawada et al., forthcoming). Likewise, species-
specific GnRHR-III has been identified in teleost species (14, 15),
and lamprey has also three GnRHRs which are genetically inde-
pendent of teleost GnRHR subtypes (16). Such species-specific
GPCR paralogs are thought to determine the functional diversity
and physiological regulatory systems, because GPCR paralogs can
form species-specific GPCR heterodimers, which, if expressed in
the same cells, control the unique expansion and fine-tuning of
GPCR-mediated signaling pathways (Figure 2), as shown for C.
intestinalis GnRHRs (73, 74). In other words, heterodimerization
involving species-specific GPCRs is highly likely to contribute to
the evolution and diversification of organisms to a large extent.
FIGURE 2 | Hypothetical scheme of the emergence of functional
diversity via species-specific GPCR heterodimerization. All the species
conserve the authentic orthologous GPCR (red), whereas species B and C
possess one or two additional species-specific paralogs, respectively (blue,
yellow, and green). While no heterodimer involving the orthologous GPCR is
formed, species-specific GPCR heterodimers occur in species B and C.
such species-specific heterodimers are highly likely to be closely related
functional diversity of a certain GPCR family, ultimately leading to the
evolution and diversification of organisms to a large extent.
CONCLUSION AND PERSPECTIVES
To date, GPCR heterodimerization has attracted keen attentions
in light of biochemical and pharmacological features of GPCRs
and the development of drugs with high selectivity, given that
GPCR heterodimerization has been explored almost exclusively
in mammals, except for C. intestinalis GnRHRs. Nevertheless,
recent studies in various fields suggest that GPCR heterodimer-
ization plays crucial roles in the regulation of the HPG axis and
the evolution and diversification of reproductive functions. In
this regard, of special interest is whether kisspeptin receptors
or GnIH receptors heterodimerize with any GPCRs. Moreover,
heterodimerization involving species-specific GPCR paralogs is
expected to be responsible for the emergence of unique physio-
logical functions in the respective organisms. Accordingly, com-
bined with the fact that GPCRs form corresponding heterodimers
after translation, investigation of GPCR heterodimerization in
non-mammalian organisms will provide novel insight into the
generation of biodiversity directed by a post-translational protein
interaction.
In keeping with this issue, of particular interest is the clar-
ification of the in vivo functional correlation between GPCR
heterodimerization and biological events. Real-time imaging of
GPCR heterodimerization could enable the visualization of bio-
logical functions of GPCR heterodimers of interest. Although this
experimental strategy is unlikely to be applied to mammals, organ-
isms equipped with transparent or semi-transparent skins, includ-
ing ascidian, medaka, or zebrafish, are useful for live-imaging of
GPCR heterodimers (50). Such studies are currently in progress in
our laboratory.
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